Department of Pharmacy, University of Salerno, 84084, Fisciano, Italy.
Clinical Pathology, Pausilipon Hospital, A.O.R.N Santobono-Pausilipon, 80123, Naples, Italy.
Commun Biol. 2022 Aug 20;5(1):848. doi: 10.1038/s42003-022-03781-3.
Plant extracellular vesicles (EVs) concentrate and deliver different types of bioactive molecules in human cells and are excellent candidates for a next-generation drug delivery system. However, the lack of standard protocols for plant EV production and the natural variations of their biomolecular cargo pose serious limitation to their use as therapeutics. To overcome these issues, we set up a versatile and standardized procedure to purify plant EVs from hairy root (HR) cultures, a versatile biotechnological system, already successfully employed as source of bioactive molecules with pharmaceutical and nutraceutical relevance. Herewith, we report that HR of Salvia dominica represent an excellent platform for the production of plant EVs. In particular, EVs derived from S. dominica HRs are small round-shaped vesicles carrying typical EV-associated proteins such as cytoskeletal components, chaperon proteins and integral membrane proteins including the tetraspanin TET-7. Interestingly, the HR-derived EVs showed selective and strong pro-apoptotic activity in pancreatic and mammary cancer cells. These results reveal that plant hairy roots may be considered a new promising tool in plant biotechnology for the production of extracellular vesicles for human health.
植物细胞外囊泡(EVs)在人体细胞中浓缩并传递不同类型的生物活性分子,是下一代药物输送系统的绝佳候选者。然而,由于缺乏植物 EV 生产的标准方案,以及其生物分子货物的天然变异,严重限制了它们作为治疗药物的应用。为了克服这些问题,我们建立了一种通用且标准化的程序,从发根(HR)培养物中纯化植物 EV,发根是一种多功能的生物技术系统,已成功用作具有药物和营养相关性的生物活性分子的来源。在此,我们报告说,Salvia dominica 的 HR 是生产植物 EV 的极好平台。特别是,源自 S. dominica HR 的 EV 是带有典型 EV 相关蛋白的小圆形囊泡,例如细胞骨架成分、伴侣蛋白和包括四跨膜蛋白 TET-7 在内的完整膜蛋白。有趣的是,HR 衍生的 EV 在胰腺和乳腺癌细胞中表现出选择性和强烈的促凋亡活性。这些结果表明,植物发根可能被认为是植物生物技术中的一种新的有前途的工具,可用于生产用于人类健康的细胞外囊泡。